2014 OIS@ASCRS Executive Report

2014 OIS@ASCRS Executive Report
BOSTON — The Third Annual Ophthalmology Innovation Summit (OIS@ASCRS) took place on April 24, just prior to the 2014 annual meeting of the American Society of Cataract and Refractive Surgery (ASCRS). The purpose of this conference is to support innovation by facilitating deal-flow and business partnerships between CEOs of young companies, investors, corporate executives, physicians, and academic scientists in the field of ophthalmology. A newly expanded agenda format, which more closely resembled the flagship OIS@AAO meeting, was met with rave reviews in Boston.

The program included a total of seventeen innovative companies that are treating conditions in either the anterior or posterior chambers of the eye. First time OIS presenters were EyeSonix, Anew Optics, RPS- Rapid Pathogen Screening, pSivida, CXLO, TearLab, TearScience, and Panoptes Pharma while the returnees included ClarVista Medical, PowerVision, i-Optics, WaveTec Vision Systems, Clarity Medical Systems, Avedro, Mimetogen Pharmaceuticals, Eleven Biotherapeutics, and Ocular Therapeutix.

Read the full executive report:

SHARE THIS ARTICLE WITH YOUR COLLEAGUES:

RECOMMENDED FOR YOU

Untitled (800 x 812 px) (1)

Nine Days in September: Three Pharma Plays in Gene Therapy

MicrosoftTeams-image (124)

OIS Retina@ASRS Sizes Up the Challenges in Retina Innovation

MicrosoftTeams-image (97)

Regulatory Pathways Group Has a Plan to Build on Mentor’s Work

Jeff Krall - OIS Podcast 300 - Thumbnail (1)

Solving the Dry Eye Mystery With Neurolens’ Jeffrey Krall, OD

Harlow Health

In a Busy Summer, Harrow Health Expands Beyond Compounding, Adds DTC Business

Barry Kupperman

Following Intellectual Passions, With Dr. Baruch Kupperman

About The Author

Larry Haimovitch

SUBSCRIBE TO OUR NEWSLETTER

Get The Latest News In Opthalmologic Innovation To Your Inbox.

We respect your privacy and will never send you spam.

Something went wrong. Please check your entries and try again.

SUBSCRIBE TO OIS WEEKLY

Get our monthly newsletter about the latest in opthalmologic innovation.

We respect your privacy and will never send you spam.

Something went wrong. Please check your entries and try again.

STAY CONNECTED

PODCASTS